Join our upcoming webinar to see how seqWell’s plexWell technology has benefited Addgene and the fight against COVID19. Click HERE to register today!
Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.
In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.
Founder and Chief Executive Officer
Chief Commercial Officer
Chief Technology Officer
Chief Financial Officer
Vice President, Sales & Marketing
Vice President, Business Development
Director, Research and Development